Publications en collaboration avec des chercheurs de Instituto de Salud Carlos III (36)

2023

  1. Circulating lipoprotein-carried miRNome analysis reveals novel VLDL-enriched microRNAs that strongly correlate with the HDL-microRNA profile

    Biomedicine and Pharmacotherapy, Vol. 162

2022

  1. N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study

    Clinical Microbiology and Infection, Vol. 28, Núm. 10, pp. 1391.e1-1391.e5

  2. One Year Overview and Follow-Up in a Post-COVID Consultation of Critically Ill Patients

    Frontiers in Medicine, Vol. 9

2021

  1. Epigenetics in precision medicine of cardiovascular disease

    Epigenetics in Precision Medicine (Elsevier), pp. 347-368

  2. Sex-related differences of fatty acid-binding protein 4 and leptin levels in atrial fibrillation

    Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 23, Núm. 5, pp. 682-690

2020

  1. Altered brain metabolome is associated with memory impairment in the rTG4510 mouse model of tauopathy

    Metabolites, Vol. 10, Núm. 2

  2. Association of circulating microRNAs with coronary artery disease and usefulness for reclassification of healthy individuals: The REGICOR study

    Journal of Clinical Medicine, Vol. 9, Núm. 5

  3. Development of Innovative Antiatherosclerotic Peptides through the Combination of Molecular Modeling and a Dual (Biochemical-Cellular) Screening System

    Advanced Therapeutics, Vol. 3, Núm. 8

  4. Emerging role of microRNAs in dilated cardiomyopathy: evidence regarding etiology

    Translational Research, Vol. 215, pp. 86-101

  5. LRP1-Mediated AggLDL Endocytosis Promotes Cholesteryl Ester Accumulation and Impairs Insulin Response in HL-1 Cells

    Cells, Vol. 9, Núm. 1

  6. Low-density lipoprotein receptor-related protein 1 deficiency in cardiomyocytes reduces susceptibility to insulin resistance and obesity

    Metabolism: Clinical and Experimental, Vol. 106

  7. Macrophage cholesterol efflux downregulation is not associated with abdominal aortic aneurysm (AAA) progression

    Biomolecules, Vol. 10, Núm. 4

  8. Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy

    Translational Research, Vol. 218, pp. 1-15

  9. Plasma circular RNA hsa_circ_0001445 and coronary artery disease: Performance as a biomarker

    FASEB Journal, Vol. 34, Núm. 3, pp. 4403-4414

2019

  1. Circulating miRNAs as mediators in cell-to-cell communication

    Epigenomics

  2. Circulating microRNAs in suspected stable coronary artery disease: A coronary computed tomography angiography study

    Journal of Internal Medicine, Vol. 286, Núm. 3, pp. 341-355

  3. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: A novel tool for personalized medicine?

    European Heart Journal, Vol. 40, Núm. 20, pp. 1643-1650

  4. Fatty acid binding protein 4 (FABP4) as a potential biomarker reflecting myocardial lipid storage in type 2 diabetes

    Metabolism: Clinical and Experimental, Vol. 96, pp. 12-21

  5. Plasma microRNA profiling reveals novel biomarkers of epicardial adipose tissue: A multidetector computed tomography study

    Journal of Clinical Medicine, Vol. 8, Núm. 6

  6. Publisher Correction: Soluble LRP1 is an independent biomarker of epicardial fat volume in patients with type 1 diabetes mellitus (Scientific Reports, (2018), 8, 1, (1054), 10.1038/s41598-018-19230-3)

    Scientific Reports